Bioanalytical Services Market Projected to Reach US$ 11.61 Billion by 2035, Driven by Rising FDA Approvals and Clinical Trial Activity Says Astute Analytica
GlobeNewswire Inc.
•
•By Astute Analytica
The global bioanalytical services market is expected to grow from US$ 3.96 billion in 2025 to US$ 11.61 billion by 2035 at a CAGR of 11.6%. Growth is driven by FDA Modernization Act 2.0 implementation, increased clinical trial activity, and a shift toward advanced testing methodologies like cell-based assays and LC-MS/MS platforms. Cell-based assays lead with 46.1% market share, while small molecules account for 55.4%. Oncology applications dominate at 32% share, driven by the explosive pipeline of 1,200+ Antibody-Drug Conjugates.